Other secreted PD-L1 splicing variants (without transmembrane domain) have been characterized, including in patients with non-small cell lung cancer [106], and in melanoma [48] and leukemia cells [102,107]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.